U.S. Senate · 119th Congress · S. 1302
Increasing Transparency in Generic Drug Applications Act
A bill to provide for increased transparency in generic drug applications.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Margaret Wood HassanD-NH
- Introduced
- April 3, 2025, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (6)
4 Republicans, 2 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- John W. HickenlooperD-CO
- Mike LeeR-UT
- Rand PaulR-KY
Signed on later
- James LankfordR-OKMay 8, 2025
- Jon HustedR-OHDecember 9, 2025
- Jon OssoffD-GADecember 9, 2025